| Dr Giridhar Anireddy, MD | |
|
2751 N Scenic Drive, Alamogordo, NM 88310-7829 | |
| (575) 434-2965 | |
| (575) 439-8254 |
| Full Name | Dr Giridhar Anireddy |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 2751 N Scenic Drive, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366445496 | NPI | - | NPPES |
| 40302202 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | NM20020255 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Ruidoso, NM | Home health agency |
| Gerald Champion Regional Medical Center | Alamogordo, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alamogordo Internal Medicine P.c. | 4486664133 | 2 |
| Otero County Hospital Association | 3173516606 | 133 |
News Archive
One in four women undergoing surgery for urinary incontinence has recently taken antibiotics for a urinary tract infection, a large population-based study shows.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, a species of monkey, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
As part of the Ireland Pavilion at Arab Health 2013, Lincor Solutions, the global leaders in point of care computing, will be showcasing the latest developments in MEDIVista. These include significant enhancements to the MEDIVista enterprise server, new hardware and a preview of future developments.
› Verified 1 days ago
| Entity Name | Alamogordo Internal Medicine P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477581031 PECOS PAC ID: 4486664133 Enrollment ID: O20060426000400 |
News Archive
One in four women undergoing surgery for urinary incontinence has recently taken antibiotics for a urinary tract infection, a large population-based study shows.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, a species of monkey, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
As part of the Ireland Pavilion at Arab Health 2013, Lincor Solutions, the global leaders in point of care computing, will be showcasing the latest developments in MEDIVista. These include significant enhancements to the MEDIVista enterprise server, new hardware and a preview of future developments.
› Verified 1 days ago
| Entity Name | Otero County Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861450579 PECOS PAC ID: 3173516606 Enrollment ID: O20070212000377 |
News Archive
One in four women undergoing surgery for urinary incontinence has recently taken antibiotics for a urinary tract infection, a large population-based study shows.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, a species of monkey, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
As part of the Ireland Pavilion at Arab Health 2013, Lincor Solutions, the global leaders in point of care computing, will be showcasing the latest developments in MEDIVista. These include significant enhancements to the MEDIVista enterprise server, new hardware and a preview of future developments.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Giridhar Anireddy, MD 2751 N Scenic Drive, Alamogordo, NM 88310-7829 Ph: (575) 434-2965 | Dr Giridhar Anireddy, MD 2751 N Scenic Drive, Alamogordo, NM 88310-7829 Ph: (575) 434-2965 |
News Archive
One in four women undergoing surgery for urinary incontinence has recently taken antibiotics for a urinary tract infection, a large population-based study shows.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, a species of monkey, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
As part of the Ireland Pavilion at Arab Health 2013, Lincor Solutions, the global leaders in point of care computing, will be showcasing the latest developments in MEDIVista. These include significant enhancements to the MEDIVista enterprise server, new hardware and a preview of future developments.
› Verified 1 days ago
Mr. George M Massoud, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2559 N Scenic Dr, Suite F, Alamogordo, NM 88310 Phone: 575-434-3225 Fax: 575-434-8671 | |
Nasser Jamal Alqassem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 9th St, Ste A, Alamogordo, NM 88310 Phone: 505-437-8411 Fax: 505-443-1753 | |
Dr. Stefan Korec, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2559 Medical Dr, Suite G., Alamogordo, NM 88310 Phone: 575-437-8126 Fax: 575-437-8205 | |
Ferial Abood, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2559 Medical Dr Ste C, Alamogordo, NM 88310 Phone: 575-439-8220 Fax: 575-443-1818 | |
Stephen J Durant, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 9th St Ste A, Alamogordo, NM 88310 Phone: 575-437-8411 Fax: 575-443-1753 | |
Dennis Victor Worthington, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2539 Medical Dr, Suite 107, Alamogordo, NM 88310 Phone: 575-446-5940 Fax: 575-446-5944 |